UK markets closed

AbbVie Inc. (0QCV.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
146.95-0.42 (-0.28%)
At close: 07:14PM BST
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.59
52-week change 3N/A
S&P500 52-week change 3-10.33%
52-week high 3147.40
52-week low 3146.93
50-day moving average 3N/A
200-day moving average 3N/A

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 51.5B
Implied shares outstanding 6N/A
Float 81.77B
% held by insiders 10.13%
% held by institutions 171.71%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 35.71
Trailing annual dividend yield 33.87%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)31 Dec 2022


Profit margin 20.39%
Operating margin (ttm)38.97%

Management effectiveness

Return on assets (ttm)9.91%
Return on equity (ttm)72.39%

Income statement

Revenue (ttm)58.05B
Revenue per share (ttm)32.78
Quarterly revenue growth (yoy)1.60%
Gross profit (ttm)41.53B
Net income avi to common (ttm)11.78B
Diluted EPS (ttm)6.97
Quarterly earnings growth (yoy)-38.80%

Balance sheet

Total cash (mrq)9.23B
Total cash per share (mrq)5.22
Total debt (mrq)64.58B
Total debt/equity (mrq)373.59
Current ratio (mrq)0.96
Book value per share (mrq)9.75

Cash flow statement

Operating cash flow (ttm)24.94B
Levered free cash flow (ttm)22.76B